Article Details

Verdiva Bio launches with $411m in funding to advance obesity drugs

Retrieved on: 2025-01-09 15:44:13

Tags for this article:

Click the tags to see associated articles and topics

Verdiva Bio launches with $411m in funding to advance obesity drugs. View article details on hiswai:

Excerpt

RA Capital Management, OrbiMed, Logos Capital, Lilly Asia Ventures and LYFE Capital also participated. Verdiva intends to pioneer next-generation oral ...

Article found on: www.outsourcing-pharma.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up